EPIDEMIOLOGY AND SCREENING OF DEVELOPMENTAL DYSPLASIA OF THE HIP IN EUROPE; A SCOPING REVIEW.

Developmental Dysplasia of the Hip (DDH) includes a wide range of deformities of the hip, such as congenital dysplasia, subluxation, and dislocation. It is usually identified through neonatal screening during the first 6-8 weeks of life. The incidence of DDH ranges from 1–7% in neonates among some populations but this may vary among different ethnicities and countries.

The aim of this study is to summarize the existing data regarding the incidence of DDH and screening tests among European countries. 

This study is a scoping review of the literature.

The incidence of DDH presents fluctuations, not only among European countries, but also within the same country. A consensus about the ideal age for screening has not been reached to date and there is no unanimity regarding the screening methods of DDH in Europe (universal screening methods vs. screening of high-risk cases). 

More robust data is needed to conclude which screening approach is associated with improved long-term outcomes.